6th India Pharmaceutical Forum 2021 - IPA, Indian Pharmaceutical Alliance

Event

6th India Pharmaceutical Forum 2021

6th India Pharmaceutical Forum 2021- Flyer 1

6th India Pharmaceutical Forum 2021- Flyer 2

6th India Pharmaceutical Forum 2021- Flyer 3

6th India Pharmaceutical Forum 2021 - Agenda

Subject Matter Experts from Global Regulatory Agencies, Industry, Industry Organisations and Consultants

Session 4 : EDQM Real time remote inspections- Dr Cristina Baccarelli

Session 4 : Inspection during COVID-19 and overview of GDUFA III negotiations- Mr David Gaugh

Session 4 : MHRA Remote Inspection Strategies- Ms Paula Walker

Session 6 : EHS and Sustainability- Mr Koen Laenen

Session 7 : Global view on regulatory affairs- Dr Rajkiran Jain

Session 7 : Global view on regulatory affairs- Mr Anthony Lakavage

Session 7 : Global view on regulatory affairs- Mr K S Babu

Session 7 : Global view on regulatory affairs- Ms Beata Stepniewska

Session 8 : Contamination Control- Mr Rajendra Kumar Das

Session 11 : Future Challenges and Objectives for PDA in AsiaPac- Mr Richard Johnson

Session 11 : Integrated Risk Management from Design to Delivery- Dr Ghada Haddad

Session 12 : Quality compliance culture and empowerment in the new normal- Dr Ranjana Pathak

Session 13 : Panel Discussion - Digitalisation, automation and AI in operations- Ms Geena Malhotra

‘6th India Pharmaceutical Forum 2021 (IPF)’ Teaser

6th India Pharmaceutical Forum: CEO Panel Discussion: COVID-19 impact on Pharmaceutical Industry

6th IP Forum: Day 1 – Session 7 by Ms. Beata Stepniewska, Medicines for Europe

6th India Pharmaceutical Forum: Day 1 - Panel Discussion on 'New paradigm in Quality Management'

6th IP Forum: Day 1 – Session 4 by Ms. Paula Walker – Deputy Group Manager, MHRA

6th IP Forum: Day 1 – Session 4 by Mr. David Gaugh – Senior VP, AAM

6th India Pharmaceutical Forum: Day 1 - Session 4 by Dr. Cristina Baccarelli – GMP Inspector, EDQM

6th IP Forum: Day 2 – Session 6 by Mr. Koen Laenen, Medicines for Europe

6th IP Forum: Day 2 – Session 8 by Mr. Rajendra Kumar Das, Sun Pharma

6th IP Forum: Day 2 – Session 10 on ‘Industry-Academia Collaboration’

6th IP Forum: Day 3 – Session 11 by Mr. Richard Johnson

6th IP Forum: Day 3 – Session 11 by Dr. Ghada Haddad – Exec. Director, Merck & Co.

6th IPF 2021: Day 3 - Session 12 on 'Quality compliance culture & empowerment in the new-normal'

24 February 2021 - 26 February 2021
Online